news 2024

US researchers have participated in a study that reveals how alterations in brain development in psychosis may be related to metabolism and neurotransmitters. Researchers from the University of Seville have participated, together with representatives from other Spanish, British, American and Canadian research centers, in a recent scientific study that has identified important anomalies in the brain maturation of individuals with psychosis.

Research at the Instituto de Biomedicina de Sevilla (IBiS) shows that the combination of melatonin and methylprednisolone effectively protects against multiple sclerosis in animal models, allowing to reduce up to four times the dose of corticosteroids.

The Institute for Integrative Systems Biology (UV-CSIC) has conducted the first comprehensive analysis of all mutations in the protein set of coxsackievirus B3, which causes severe heart inflammation. The findings, published in Plos Biology, will help to identify regions of the virus genome with low tolerance to mutations, facilitating the development of drugs targeting these areas.

A team from the Autonomous University of Madrid (UAM) has developed paper sensors with rare-earth nanoparticles capable of detecting small concentrations of glucose in aqueous solutions. The work, published in the journal Colloids and Surfaces B: Biointerfaces , offers a non-invasive alternative for measuring glucose levels in patients with diabetes, eliminating the need to prick fingers to draw blood.

The University of Valencia, together with the INCLIVA Health Research Institute of the Hospital Clínic Universitari de València, has led a study involving the Hospital La Fe de València and Oftalvist and with the collaboration of the Universitat Politècnica de València to analyse the most effective doses of anti-VEGF to treat the retinopathy of prematurity and to avoid adverse effects.

The pharmaceutical drug, named ATX-01, has just been authorised to start clinical trials in the US. This new therapeutic advance gives hope to those suffering from Myotonic Dystrophy type 1, an hereditary degenerative disease currently lacking of effective treatment.